Verve stock price.

What happened to Verve Therapeutics’s price movement after its last earnings report? Verve Therapeutics reported an EPS of -$0.72 in its last earnings report, beating expectations of -$0.905. Following the earnings report the stock price went up 24.833%. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of …View Verve Therapeutics, Inc. VERV stock quote prices, financial information, real-time forecasts, and company news from CNN.View Verve Therapeutics, Inc. VERV stock quote prices, financial information, real-time forecasts, and company news from CNN.

Verve Therapeutics Inc’s Stock Price Change Based on Its Q3 Earnings Report. The stock market is considered to always be “forward-looking,” which means share prices are established based on the expectations that prospective investors have for the future earnings power of the company.

2 days ago · Nov. 29. MT. Verve Therapeutics Prices Offering of Common Shares, Concurrent Private Placement for Proceeds of $148 Million. Nov. 29. MT. Verve Therapeutics Proposes Common Stock Public Offering, Concurrent Private Placement -- Shares Slump After Hours. Nov. 28. MT. Verve Therapeutics, Inc. announced that it expects to receive $35 million in ...

Jan 5, 2024 · The latest price target for . Verve Therapeutics (NASDAQ: VERV) was reported by Cantor Fitzgerald on September 13, 2023.The analyst firm set a price target for $22.00 expecting VERV to rise to ... In addition, Verve has granted the underwriters a 30-day option to purchase up to 1,875,000 additional shares of its common stock at the public offering price, less the underwriting discounts and ...NASDAQ:VERV Verve Therapeutics (VERV) Stock Price, News & Analysis $13.13 +0.07 (+0.54%) (As of 02/21/2024 ET) Compare Today's Range $12.65 $13.21 50 …Information on stock, financials, earnings, subsidiaries, investors, and executives for Verve Therapeutics. Use the PitchBook Platform to explore the full profile. Request a free trial Log in. Products; Solutions; ... Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; $10.95: $11.46: $8.22 - $23.54: $881M: 80.4M: 1.58M ...Verve Therapeutics Inc stock price (VERV) NASDAQ: VERV. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Verve Therapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.

Nov 28, 2023 · In addition, Verve expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering at the public offering price ...

View today's Verve Therapeutics Inc stock price and latest VERV news and analysis. Create real-time notifications to follow any changes in the live stock price.

Zentalis Pharmaceuticals Inc. 11.36. -0.23. -1.98%. Get Verve Therapeutics Inc (VERV:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Webull offers VERV Ent Holdg (VERV) historical stock prices, in-depth market analysis, NASDAQ: VERV real-time stock quote data, in-depth charts, free VERV options chain data, and a fully built financial calendar to help you invest smart. 4 days ago · 6 analysts have issued 1-year target prices for Verve Therapeutics' stock. Their VERV share price targets range from $22.00 to $55.00. On average, they predict the company's share price to reach $34.25 in the next twelve months. This suggests a possible upside of 160.9% from the stock's current price. 13.36. 13.36. 353,800. *Close price adjusted for splits. **Close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for …Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Verb Technology Company, Inc. (VERB) stock quote, history, news and other vital information to help you with your stock trading and investing.

Complete Verve Therapeutics Inc. stock information by Barron's. View real-time VERV stock price and news, along with industry-best analysis.Nov 14, 2023 · Data showed that a single infusion of Verve's genetic treatment led to drops of 40% to 55% in the “bad” LDL cholesterol. ... who’s got a $55 price target on Verve stock. LLY. +2.03%. VERV. +4.59%. Verve Therapeutics (NASDAQ: VRV) stock saw a significant rise of 24% to $11.69 on Tuesday, following the announcement of an expanded partnership with pharmaceutical ...Quotes and Performance More quotes Highs and lows 1 week 12.00 13.55 1 month 10.31 13.59Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement. BOSTON, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc. (Nasdaq: VERV), a ... SPX. -0.48%. Verve Therapeutics Inc. shares VERV, -1.43% fell 40% premarket on Monday after the biotech company on Sunday released early-stage clinical …

4 days ago · View Verve Therapeutics, Inc VERV investment & stock information. Get the latest Verve Therapeutics, Inc VERV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Verve Therapeutics Inc. (VERV) is a biotech company that develops gene-editing treatments for heart disease. The stock price, performance, news, and analysis of …The stock closed last Friday at $23.71 and opened on Monday at $25.06. It hit a weekly high of $36.79 on Wednesday. Over the past 52 weeks, the stock's low is $10.70 and its high is $78.Lilly will pay $250 million to Beam for the rights to three gene-editing drugs from Verve. VERV stock and Beam stock skyrocketed. ... Issi has an outperform rating on VERV stock and a 35 price ...Jul. 15, 2021, 10:00 AM. CAMBRIDGE, Mass., July 15, 2021 /PRNewswire/ -- Wearable robotics startup Verve Motion today announced it has raised $15 million in Series A funding, led by Construct ...VERVE-101 & VERVE-102; VERVE 201; Culture & Careers ; Utility Nav. Patients & Caregivers ; Medical Professionals ; ... Stock Quote & Chart. Sub Nav - Stock Information. According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...Verve Therapeutics Inc’s Stock Price Change Based on Its Q3 Earnings Report. The stock market is considered to always be “forward-looking,” which means share prices are established based on the expectations that prospective investors have for the future earnings power of the company. In fact, expectations play a key role in …Verve Therapeutics, Inc. 201 Brookline Avenue Suite 601 Cambridge, MA 02215 United States 617 603 0070 https://www.vervetx.com Sector(s) : Healthcare Industry : Biotechnology Full Time Employees : 204

Track Verve Therapeutics Inc (VERV) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

Zentalis Pharmaceuticals Inc. 11.36. -0.23. -1.98%. Get Verve Therapeutics Inc (VERV:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Verve Therapeutics - VERV - Stock Price Today - Zacks Verve Therapeutics (VERV) (Delayed Data from NSDQ) $13.09 USD -0.19 (-1.43%) Updated Feb 16, 2024 …Details. Verve 3 Disc is an easy-riding hybrid bike designed for comfort on roads, paths, and city streets. The highest-end model in the Verve family features an upgraded drivetrain, stable puncture-resistant tires, and vibration-reducing handlebars and grips that make your ride even more comfortable.3 days ago · The Verve Therapeutics, Inc. stock price gained 1.45% on the last trading day (Thursday, 22nd Feb 2024), rising from $13.13 to $13.32. During the last trading day the stock fluctuated 4.95% from a day low at $13.12 to a day high of $13.77. The price has risen in 7 of the last 10 days and is up by 21.64% over the past 2 weeks. Since reporting some early-stage clinical data from one of its gene editing programs on Nov. 12, share prices of Verve Therapeutics (NASDAQ: VERV) are down 42%. But contrary to what you may be ...Verve Therapeutics Inc stock price (VERV) NASDAQ: VERV. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Verve Therapeutics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.The stock closed last Friday at $23.71 and opened on Monday at $25.06. It hit a weekly high of $36.79 on Wednesday. Over the past 52 weeks, the stock's low is $10.70 and its high is $78.2 days ago · Verve Therapeutics Inc. (VERV) is a biotech company that develops gene-editing treatments for heart disease. The stock price, performance, news, and analysis of VERV are shown on this web page. As of Jan 17, 2024, the stock closed at $12.49, down 11.28% from the previous day. Verve Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The company's twist on CRISPR appears to work as intended but that didn't stop this biotech's stock price from collapsing. VERV: 11.54 (-2.62%) After Its Stock Crashed 42% in 1 Day, Is Verve Therapeutics ...Find out the direct holders, institutional holders and mutual fund holders for Verve Therapeutics, Inc. (VERV).The Wall Street analyst predicted. that Verve Therapeutics's share price could reach $22.00 by Sep 13, 2024. The average Verve Therapeutics stock price prediction forecasts a potential upside of 68.45% from the current VERV share price of $13.06. Feb 16, 2024 · Stock Price Forecast. The 5 analysts with 12-month price forecasts for Verve Therapeutics stock have an average target of 34.4, with a low estimate of 22 and a high estimate of 55. The average target predicts an increase of 162.80% from the current stock price of 13.09.

Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing.MarketWatch IBD DJIA 39131.53 0.16% S&P 500 5088.80 0.03% U.S. 10 Yr 6/32 Yield 4.254% Euro 1.0822 0.02% Subscribe Sign In Verve Therapeutics Inc. VERV …What happened to Verve Therapeutics’s price movement after its last earnings report? Verve Therapeutics reported an EPS of -$0.72 in its last earnings report, beating expectations of -$0.905. Following the earnings report the stock price went up 24.833%. That’s already above the company’s daily average trading volume of about 988,000 shares. VERV stock is down 39.1% as of Monday morning. The stock was also down 16.9% year-to-date when markets ...Instagram:https://instagram. nbc news nowcheapest flights to cancunscarlet.songbird fleetwood mac Verve Therapeutics (VERV) Insider Trading & Ownership. $13.13. +0.07 (+0.54%) (As of 02/21/2024 ET) Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media. Current. Insider Ownership. Percentage. 21.40%. tis the damn seasonolga tanon Certain Restricted Stock Units of Verve Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 28-JAN-2024. Jan. 27: CI ... Verve Therapeutics Prices Offering of Common Shares, Concurrent Private Placement for Proceeds of $148 Million Nov. 29: MT ...The Trade: Verve Therapeutics, Inc. (NASDAQ:VERV) 10% owner Krishna Yeshwant bought a total of 1,800,000 shares at an average price of $10.00. To acquire these shares, it cost around $18 million. canadian visa application center Find the latest Verve Therapeutics, Inc. (VERV) stock quote, history, news and other vital information to help you with your stock trading and investing.Verve Therapeutics (VERV) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further ...